T2	Gene_or_protein 14 18	KRAS 
T3	Chemical 83 92	erlotinib 
T4	Limited_variation 14 26	KRAS -mutant
T5	Chemical 97 109	chemotherapy
T6	Chemical 83 109	erlotinib and chemotherapy
T7	Pharmacodynamic_phenotype 47 64	clinical outcomes
T8	Disease 14 32	KRAS -mutant NSCLC
R3	isAssociatedWith Arg1:T3 Arg2:T8	
R2	decreases Arg1:T4 Arg2:T7	
R1	treats Arg1:T6 Arg2:T8	
R4	isAssociatedWith Arg1:T6 Arg2:T7	
#1	AnnotatorNotes R1	neg
